1. Home
  2. TOPS vs MTNB Comparison

TOPS vs MTNB Comparison

Compare TOPS & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TOP Ships Inc.

TOPS

TOP Ships Inc.

N/A

Current Price

$2.15

Market Cap

2.2M

ML Signal

N/A

Logo Matinas Biopharma Holdings Inc.

MTNB

Matinas Biopharma Holdings Inc.

N/A

Current Price

$0.82

Market Cap

2.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TOPS
MTNB
Founded
2000
2013
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.6M
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
TOPS
MTNB
Price
$2.15
$0.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 303.3K
49.4K
Earning Date
09-16-2026
11-16-2026
Dividend Yield
★ 35.44%
N/A
EPS Growth
N/A
★ 59.84
EPS
★ N/A
N/A
Revenue
N/A
★ $119,750.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.14
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.26
$0.15
52 Week High
$7.40
$3.16

Technical Indicators

Market Signals
Indicator
TOPS
MTNB
Relative Strength Index (RSI) 63.71 35.09
Support Level $0.59 $0.56
Resistance Level $2.31 $0.89
Average True Range (ATR) 0.31 0.18
MACD 0.06 -0.05
Stochastic Oscillator 53.44 5.17

Price Performance

Historical Comparison
TOPS
MTNB

About TOPS TOP Ships Inc.

TOP Ships Inc owns tanker vessels throughout the world. The Company is an international owner and operator of modern, fuel-efficient eco-tanker vessels, focusing on the transportation of crude oil, petroleum products (both clean and dirty), and bulk liquid chemicals. It generates revenue from the Time Charter agreements. The company operates in two reportable segments: (i) the tanker segment and (ii) the megayacht segment.

About MTNB Matinas Biopharma Holdings Inc.

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.

Share on Social Networks: